Healthcare provider profile · identity verified

Thomas D. Robbins, M.D.

Family Practice · JEFFERSON CITY, MO · NPI 1508836115

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	521	69
Furosemide	Furosemide	322	43
Lisinopril	Lisinopril	321	52
Donepezil Hcl	Donepezil Hcl	274	28
Atorvastatin Calcium	Atorvastatin Calcium	265	69
Amlodipine Besylate	Amlodipine Besylate	254	52
Pantoprazole Sodium	Pantoprazole Sodium	248	53
Potassium Chloride	Potassium Chloride	232	42
Sertraline Hcl	Sertraline Hcl	187	31
Tamsulosin Hcl	Tamsulosin Hcl	171	34
Metoprolol Succinate	Metoprolol Succinate	163	31
Losartan Potassium	Losartan Potassium	142	27
Eliquis	Apixaban	139	33
Buspirone Hcl	Buspirone Hcl	132	21
Duloxetine Hcl	Duloxetine Hcl	126	19
Gabapentin	Gabapentin	125	33
Mirtazapine	Mirtazapine	118	15
Trazodone Hcl	Trazodone Hcl	116	25
Metoprolol Tartrate	Metoprolol Tartrate	112	18
Quetiapine Fumarate	Quetiapine Fumarate	110	18
Citalopram Hbr	Citalopram Hydrobromide	105	20
Clopidogrel	Clopidogrel Bisulfate	92	15
Montelukast Sodium	Montelukast Sodium	91	14
Carbidopa-Levodopa	Carbidopa/Levodopa	87	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	87	16
Rosuvastatin Calcium	Rosuvastatin Calcium	81	19
Memantine Hcl	Memantine Hcl	80	15
Famotidine	Famotidine	79	22
Omeprazole	Omeprazole	76	23
Ropinirole Hcl	Ropinirole Hcl	73	14
Metformin Hcl	Metformin Hcl	70	16
Myrbetriq	Mirabegron	69	suppressed
Finasteride	Finasteride	68	16
Tramadol Hcl	Tramadol Hcl	68	19
Carvedilol	Carvedilol	62	27
Allopurinol	Allopurinol	60	14
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	58	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	51	18
Xarelto	Rivaroxaban	51	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	47	suppressed
Meloxicam	Meloxicam	43	11
Divalproex Sodium	Divalproex Sodium	42	suppressed
Clonidine Hcl	Clonidine Hcl	41	suppressed
Metolazone	Metolazone	38	suppressed
Simvastatin	Simvastatin	38	16
Irbesartan	Irbesartan	37	suppressed
Lorazepam	Lorazepam	35	15
Carbamazepine	Carbamazepine	34	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	34	suppressed
Naproxen	Naproxen	34	suppressed
Cephalexin	Cephalexin	32	11
Chlorthalidone	Chlorthalidone	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Baclofen	Baclofen	31	11
Clonazepam	Clonazepam	30	12
Latanoprost	Latanoprost	30	11
Meclizine Hcl	Meclizine Hcl	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	14
Pravastatin Sodium	Pravastatin Sodium	29	13
Prazosin Hcl	Prazosin Hcl	29	suppressed
Spironolactone	Spironolactone	28	suppressed
Nebivolol Hcl	Nebivolol Hcl	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	11
Metformin Hcl Er	Metformin Hcl	25	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Nystatin	Nystatin	23	17
Ondansetron Odt	Ondansetron	22	15
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Digoxin	Digoxin	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	12
Memantine Hcl Er	Memantine Hcl	21	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	21	suppressed
Atenolol	Atenolol	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Lurasidone Hcl	Lurasidone Hcl	20	suppressed
Sotalol Af	Sotalol Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Flecainide Acetate	Flecainide Acetate	18	suppressed
Gemtesa	Vibegron	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Rexulti	Brexpiprazole	18	suppressed
Risperidone	Risperidone	18	suppressed
Silodosin	Silodosin	18	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	11
Alendronate Sodium	Alendronate Sodium	16	suppressed
Donepezil Hcl Odt	Donepezil Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Sotalol	Sotalol Hcl	15	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Topiramate	Topiramate	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Invokana	Canagliflozin	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Colchicine	Colchicine	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error